Abhishek Jain compensation by year
CareDx Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $318,917 | $405,000 | $411,169 | $282,100 |
| Bonus | $0 | $100,000 | $300,000 | $0 |
| Stock awards | $904,723 | $1,924,614 | $1,549,738 | $1,557,034 |
| Option awards | $1,013,007 | $481,973 | $0 | $0 |
| Non-equity incentive | $104,260 | $174,300 | $493,403 | $309,526 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $2,400 | $8,820 | $8,400 | $489,274 |
| Total | $2,343,307 | $3,094,707 | $2,762,710 | $2,637,934 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CareDx, Inc. DEF 14A filed April 27, 2026, accession 0001217234-26-000028, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CareDx, Inc. filed document, accession 0001217234-26-000028. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 72,717 | $1,369,988 | — |
| RSU | 55,580 | $1,047,127 | — |
| RSU | 42,550 | $801,642 | — |
| PSU | 23,820 | $448,769 | — |
| RSU | 5,537 | $104,317 | — |
| RSU | 3,750 | $70,650 | — |
| RSU | 637 | $12,001 | — |
| RSU | 500 | $9,420 | — |
| Option | 212 | — | $32.55 |
| Option | 83 | — | $25.78 |
| Option | 1,042 | — | $24.07 |
| Option | 12,604 | — | $18.47 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CareDx, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.
Change-in-control & termination
estimated payments CareDx discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $482,183 | — | — | — |
Per the Potential Payments Upon Termination or Change in Control table in CareDx, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
CareDx’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| John Hanna | President and Chief Executive Officer | $7,179,699 |
| Keith Kennedy | Chief Operating Officer and Chief Financial Officer | $3,219,231 |
| Abhishek Jain · this page | Former Chief Financial Officer | $2,637,934 |
| Jessica Meng | Chief Commercial Officer | $2,579,380 |
| Jeffrey Novack | General Counsel and Secretary | $1,239,552 |
| Nathan Smith | Former Chief Financial Officer | $967,959 |
The full CareDx compensation record
free company briefThis page is one person within CareDx's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CareDx proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CareDx's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CareDx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CDNA
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.